New filler aims to outlast current options for deep smile lines

NCT ID NCT06984835

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study compares two injectable fillers for nasolabial folds (the lines from nose to mouth). One side of the face gets the experimental filler ELLANSÉ®-S, the other gets the standard filler Radiesse®. About 126 adults with moderate to severe lines will be followed for up to 24 months to see which side holds up better and how safe each is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ELLANSÉ®-S, a dermal filler made of polycaprolactone and carboxymethylcellulose gel, injected into nasolabial folds
What this could lead to
If it works, this could offer a longer-lasting option for smoothing deep smile lines.
What could go wrong
This is a mid-sized trial comparing two fillers, so results may not apply to all skin types or guarantee superiority. Risks include swelling, bruising, or uneven results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASOLABIAL FOLDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advanced Dermatology of Michigan

    Warren, Michigan, 48088, United States

  • Callender Center for Clinical Research

    Glenn Dale, Maryland, 20769, United States

  • Clinical Testing of Beverly Hills

    Encino, California, 91436, United States

  • DMR Research, PLLC

    Westport, Connecticut, 06880, United States

  • Investigate MD

    Scottsdale, Arizona, 86260, United States

  • Skin Research Institute LLC

    Miami, Florida, 33146, United States

  • Skincare Physicians

    Chestnut Hill, Massachusetts, 02467, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.